James I E, Dodds R A, Lee-Rykaczewski E, Eichman C F, Connor J R, Hart T K, Maleeff B E, Lackman R D, Gowen M
Department of Cellular Biochemistry, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania, USA.
J Bone Miner Res. 1996 Nov;11(11):1608-18. doi: 10.1002/jbmr.5650111104.
The identification and purification of human osteoclast precursors is essential to further our understanding of the mechanisms that control human osteoclast differentiation. Osteoclastoma tissue potentially provides a rich source of human osteoclast precursors, and in previous studies we have demonstrated the existence of a population of mononuclear cells within this tissue that is reactive with osteoclast-selective vitronectin receptor monoclonal antibodies. In this study, mononuclear cells expressing the vitronectin receptor, as defined by their ability to react with a murine monoclonal antibody to the beta 3 chain of the vitronectin receptor (87MEM1), were isolated from collagenase digests of osteoclastoma tissue using a fluorescence activated cell sorter. Based on their fluorescence signal and size, approximately 2-3% of the viable cells (typically 2 x 10(5)) were obtained and prepared for further phenotyping. The isolated cells demonstrated a number of phenotypic characteristics of osteoclasts: positive tartrate-resistant acid phosphatase (TRAP) activity, reactivity with human osteoclast-selective antibodies, expression of calcitonin receptors, cathepsin K (a novel osteoclast-selective cysteine proteinase) mRNA, and osteopontin mRNA and protein. These phenotypic characteristics were also detected in mononuclear cells within cryostat sections of the native osteoclastoma tissue as well as in resorption lacunae of sections of human bone. In contrast, isolated peripheral blood monocytes were negative for TRAP activity and osteopontin expression and, unlike the osteoclastoma-derived cells, demonstrated strong nonspecific esterase activity. Significantly, when the osteoclastoma-derived 87MEM1 positive cells were cocultured on whale dentine for 1-3 weeks with stromal cells, extensive resorption of the dentine surface was observed. This is the first demonstration of the purification of human osteoclast precursors. These cells provide an homogeneous cell population for studying cellular events that occur during human osteoclast differentiation.
鉴定和纯化人破骨细胞前体对于深化我们对控制人破骨细胞分化机制的理解至关重要。骨巨细胞瘤组织可能是人破骨细胞前体的丰富来源,在先前的研究中,我们已证明该组织内存在一群与破骨细胞选择性玻连蛋白受体单克隆抗体发生反应的单核细胞。在本研究中,利用荧光激活细胞分选仪从骨巨细胞瘤组织的胶原酶消化物中分离出表达玻连蛋白受体的单核细胞,其依据是它们与针对玻连蛋白受体β3链的鼠单克隆抗体(87MEM1)发生反应的能力。根据其荧光信号和大小,获得了约2 - 3%的活细胞(通常为2×10⁵个)并准备进行进一步的表型分析。分离出的细胞表现出破骨细胞的一些表型特征:抗酒石酸酸性磷酸酶(TRAP)活性呈阳性、与人破骨细胞选择性抗体发生反应、降钙素受体表达、组织蛋白酶K(一种新型破骨细胞选择性半胱氨酸蛋白酶)mRNA以及骨桥蛋白mRNA和蛋白。在天然骨巨细胞瘤组织的低温切片内的单核细胞以及人骨切片的吸收陷窝中也检测到了这些表型特征。相比之下,分离出的外周血单核细胞TRAP活性和骨桥蛋白表达呈阴性,并且与骨巨细胞瘤来源的细胞不同,表现出强烈的非特异性酯酶活性。重要的是,当将骨巨细胞瘤来源的87MEM1阳性细胞与基质细胞在鲸牙质上共培养1 - 3周时,观察到牙质表面有广泛的吸收。这是首次证明人破骨细胞前体的纯化。这些细胞为研究人破骨细胞分化过程中发生的细胞事件提供了一个同质的细胞群体。